SCHEMBL254593

SCHEMBL254593

O=C(I)c1cccc(Nc2nc3ccccc3[nH]2)c1

nearest known ligand 0.79

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 1/20 0.79
DDX3X O00571 1/20 0.57
NPC1 O15118 6/20 0.55
RAB9A P51151 6/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
HDAC11 Q96DB2 4/20 0.54
PKM P14618 2/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
MAOB P27338 1/20 0.53
ADORA2A P29274 1/20 0.53
HDAC6 Q9UBN7 1/20 0.52
MTOR P42345 1/20 0.51
IRAK4 Q9NWZ3 1/20 0.50
SCD O00767 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3766427 0.88 AKR1C3 (1.00) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL13058905 0.87 AKR1C3 (0.79) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL29624703 0.86 AKR1C3 (0.77) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL20096686 0.86 AKR1C3 (0.77) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL20096879 0.85 AKR1C3 (0.75) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL22703577 0.84 AKR1C3 (0.73) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL13002087 0.84 AKR1C3 (0.73) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL1999901 0.79 AKR1C3 (0.63) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL239690 0.76 MEN1 (0.75) AKR1C3DDX3XNPC1RAB9AMEN1
SCHEMBL30020996 0.76 MEN1 (0.75) AKR1C3DDX3XNPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013032527-A1 LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2013-03-07 WO disclosed
WO-2012031228-A2 LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2012-03-08 WO disclosed
WO-2008031016-A2 HETEROCYCLIC LIGANDS FOR INTEGRIN IMAGING AND THERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2008-03-13 WO disclosed